Related Experiment Videos
Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy
Simon K Law1, Brian J Song, Fei Yu
1Jules Stein Eye Institute, UCLA, Los Angeles, California 90095, USA. law@jsei.ucla.edu
Insights
Patients on anticoagulation (ACT) or antiplatelet therapy (APT) undergoing glaucoma surgery face higher risks of hemorrhagic complications. Continuing ACT during surgery significantly increases this risk, alongside high intraocular pressure.
Area of Science:
- Ophthalmology
- Cardiology
- Vascular Surgery
Background:
- Glaucoma surgery requires careful consideration of patient comorbidities and medications.
- Anticoagulation (ACT) and antiplatelet therapy (APT) are commonly used for cardiovascular and cerebrovascular protection.
- The risk of bleeding complications must be balanced against the risk of thromboembolic events in patients on ACT/APT undergoing surgery.
Purpose of the Study:
- To investigate the incidence of hemorrhagic complications in patients undergoing glaucoma surgery who are on ACT or APT.
- To identify risk factors associated with hemorrhagic complications in this patient population.
Main Methods:
- Retrospective case-control study analyzing medical records of glaucoma surgery patients.
- Comparison of patients on continuous ACT/APT with control patients not on these therapies.
- Analysis of outcomes including hemorrhagic complications and thromboembolic events.
Main Results:
- Patients on ACT/APT had a significantly higher rate of hemorrhagic complications (10.1%) compared to controls (3.7%).
- Anticoagulation therapy (ACT) was associated with a higher complication rate than antiplatelet therapy (APT) (22.9% vs 8.0%).
- Continuing ACT during surgery led to the highest complication rate (31.8%), with preoperative ACT, arrhythmia, and high intraocular pressure (IOP) identified as risk factors.
Conclusions:
- Chronic use of ACT/APT significantly increases the risk of hemorrhagic complications after glaucoma surgery.
- Perioperative ACT and elevated preoperative IOP are identified as key risk factors for these complications.
Purpose:
To determine the incidence of and risk factors for hemorrhagic complications in patients on anticoagulation (ACT) or antiplatelet therapy (APT) having glaucoma surgery.
Design:
Retrospective case-control study.
Methods:
Medical records of patients who had glaucoma surgery between July 1, 1998 and March 31, 2005 were reviewed. Patients who either used ACT/APT continuously throughout the perioperative period or discontinued its use prior to surgery were compared to case-matched control patients who were not on such therapies. Patients on ACT/APT who experienced postoperative hemorrhagic complications were compared to those who did not. Outcome measures included hemorrhagic complications and thromboembolic events.
Results:
Three hundred and forty-seven patients (eyes) who were on ACT or APT prior to glaucoma surgery had a higher rate of hemorrhagic complications than 347 control patients (10.1% vs 3.7%, respectively, P = .002). Patients on ACT had a higher rate of hemorrhagic complications than patients on APT (22.9% vs 8.0%, respectively, P = .003). Patients who continued ACT during glaucoma surgery had the highest rate of hemorrhagic complications (31.8%) when compared to patients who discontinued ACT prior to surgery or patients who used APT alone (P = .001). Hemorrhagic complications following glaucoma surgery were more frequently associated with preoperative ACT, arrhythmia, and higher preoperative and postoperative intraocular pressures (IOP).
Conclusion:
Chronic ACT/APT was associated with a statistically significant increase in the rate of hemorrhagic complications, and perioperative ACT and a high preoperative IOP are potential risk factors for hemorrhagic complications in patients undergoing glaucoma surgery.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Venous Thrombosis IV: Nursing Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Hemorrhagic Stroke l: Introduction
Venous Thrombosis III: Interprofessional Care